0000950170-25-036689.txt : 20250310 0000950170-25-036689.hdr.sgml : 20250310 20250310195901 ACCESSION NUMBER: 0000950170-25-036689 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250306 FILED AS OF DATE: 20250310 DATE AS OF CHANGE: 20250310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jensen Chrystal CENTRAL INDEX KEY: 0001564252 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21937 FILM NUMBER: 25725468 MAIL ADDRESS: STREET 1: C/O CERUS CORPORATION STREET 2: 2550 STANWELL DRIVE CITY: CONCORD STATE: CA ZIP: 94520 FORMER NAME: FORMER CONFORMED NAME: Menard Chrystal DATE OF NAME CHANGE: 20121210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CERUS CORP CENTRAL INDEX KEY: 0001020214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 680262011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 BUSINESS PHONE: 9252886000 MAIL ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 FORMER COMPANY: FORMER CONFORMED NAME: CERUS TECHNOLOGIES INC DATE OF NAME CHANGE: 19960731 4 1 ownership.xml 4 X0508 4 2025-03-06 0001020214 CERUS CORP CERS 0001564252 Jensen Chrystal C/O CERUS CORPORATION 1220 CONCORD AVE SUITE 600 CONCORD CA 94520 false true false false Chief Legal Officer true Common Stock 2025-03-06 4 A false 385000 0 A 790198 D Common Stock 2025-03-06 4 A false 69577 0 A 859775 D Common Stock 2025-03-07 4 S false 27457 1.498 D 832318 D Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer. The RSUs vest in two annual installments with 34% of the grant vesting on March 12, 2026, and 66% of the grant vesting on March 12, 2027, subject to the Reporting Person's continuous service to the Issuer through such vesting date. Represents RSUs granted pursuant to the Issuer's 2024 Equity Incentive Plan. These RSUs were granted in payment of a portion of the 2024 annual bonus awarded to the Reporting Person and were fully vested upon grant, with no expiration date. Represents shares sold pursuant to an instruction intended to comply with the requirement of Rule 10b5-1 that was elected by the Reporting Person on the date of grant to cover statutory tax withholding obligations and corresponding brokerage fees in connection with the vesting of certain restricted stock units and does not represent a discretionary sale by the reporting person. Represents a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $1.445 to $1.54 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. Chrystal N. Jensen 2025-03-10